Obstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy.
阻塞性睡眠呼吸暫停相關高血壓:文獻回顧與臨床管理策略。
Hypertens Res 2024-08-29
GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
GLP-1 受體激動劑、SGLT-2 抑制劑和阻塞性睡眠呼吸暫停:新盟友能否面對舊敵人?
Arch Med Sci Atheroscler Dis 2023-05-09
Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream?
給予胰高血糖素類藥物治療肥胖相關睡眠呼吸暫停症的重要性:一場革命還是空想?
Sleep 2024-04-25
Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study.
阻塞性睡眠呼吸暫停症患者中,持續正壓呼吸治療但非 GLP1 介導的體重減輕改善早期心血管疾病:一項隨機概念驗證研究。
Ann Am Thorac Soc 2024-03-04
The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review.
GLP-1受體激動劑對阻塞性睡眠呼吸暫停的影響:一項概覽性回顧。
Pharmacy (Basel) 2024-01-24
[Research status of glucagon-like peptide-1 receptor agonists on obstructive sleep apnea].
GLP-1受體激動劑在阻塞性睡眠呼吸暫停症的研究現狀
Zhonghua Jie He He Hu Xi Za Zhi 2024-03-08
Effect of SGLT2-Inhibitors on Polygraphic Parameters in Elderly Patients Affected by Heart Failure, Type 2 Diabetes Mellitus, and Sleep Apnea.
SGLT2抑制劑對心力衰竭、2型糖尿病和睡眠呼吸中止患者的多項測試參數的影響。
Biomedicines 2024-05-25
Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments.
阻塞性睡眠呼吸暫停症與肥胖:流行病學、病理生理學及減重治療效果的綜述。
Sleep Med Rev 2024-09-08